Bayer Issues Caution Notice After Xarelto Interstitial Pneumonia Deaths
This article was originally published in PharmAsia News
Executive Summary
Bayer issued written warnings to doctors in Japan about the anticoagulant Xarelto (rivaroxaban) after reported cases of patients developing interstitial pneumonia while taking the drug.